Regulatory

Regulatory  ·  Weekly Digest 14 June to 20 June 2025
FDA grants orphan drug designation to Medicovestor’s first-in-class ADC for pancreatic cancer

Weekly Digest – June 2025 Weekly Digest – June 2025 17 June 2025: FDA grants orphan drug designation to Medicovestor’s first-in-class ADC for pancreatic cancer The FDA has granted Orphan Drug Designation to Medicovestor’s lead candidate, ADoBind MC001, for treating […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest 14 June to 20 June 2025
Boan receives FDA IND clearance for Its CD228-directed ADC

Weekly Digest – June 2025 Weekly Digest – June 2025 17 June 2025: Boan receives FDA IND clearance for Its CD228-directed ADC Boan Biotech received FDA clearance to begin clinical trials in the U.S. for BA1302, a novel CD228-targeting ADC […]

by Sandhya Ramalingam

Continue Reading